Viewing Study NCT03127267


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-03-16 @ 6:01 AM
Study NCT ID: NCT03127267
Status: RECRUITING
Last Update Posted: 2025-09-12
First Post: 2017-04-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Sponsor: AB Science
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Amyotrophic Lateral Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amyotrophic Lateral Sclerosis View
None ALS View
None Tyrosine kinase inhibitor View
None Lou Gehrig's disease View
None Charcot's disease View
None Motor Neuron disease View
None MND View